Acceptability, Facilitators, and Barriers of Long-Acting Injectable Cabotegravir/Rilpivirine Among Youth With HIV in the United States.
Saved in:
| Title: | Acceptability, Facilitators, and Barriers of Long-Acting Injectable Cabotegravir/Rilpivirine Among Youth With HIV in the United States. |
|---|---|
| Authors: | Unternaher J; Division of Infectious Diseases, Children's National Hospital, Washington, D.C.. Electronic address: junternahe@childrensnational.org., Craddock C; Department of Global Health, The George Washington University Milken Institute School of Public Health, Washington, D.C., Koay WLA; Department of Pediatrics, Division of Infectious Diseases, Medical University of South Carolina, Charleston, South Carolina., Barnett AP; Division of Infectious Diseases, Children's National Hospital, Washington, D.C.; Division of Psychology and Behavioral Health, Children's National Hospital, Washington, D.C., Williams T; Division of Infectious Diseases, Children's National Hospital, Washington, D.C., Rakhmanina N; Division of Infectious Diseases, Children's National Hospital, Washington, D.C.; Department of Pediatrics, The George Washington University School of Medicine, Washington, D.C.; Technical Strategies and Innovation, Elizabeth Glaser Pediatric AIDS Foundation, Washington, D.C. |
| Source: | The Journal of adolescent health : official publication of the Society for Adolescent Medicine [J Adolesc Health] 2025 Dec; Vol. 77 (6), pp. 1135-1143. Date of Electronic Publication: 2025 Sep 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 9102136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1972 (Electronic) Linking ISSN: 1054139X NLM ISO Abbreviation: J Adolesc Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
